9:41
anacardio.com
Screenshot of anacardio.com
anacardio.com favicon

anacardio.com

11 technologies
VerifiedGrowingVisit329/mo$6M2811 Tech6 Leads
Deep Dive

AnaCardio: The $44M Stealth Biotech

A deep dive into the Swedish biotech quietly targeting heart failure with a novel mechanism

While most biotechs chase the same targets, AnaCardio is quietly developing a novel mechanism to improve cardiac contractility. With $44.2M in funding and a lean 28-person team, they're playing a high-stakes game in the $15B+ heart failure market.

$44.2M
Total Funding
28
Employees
$5.6M
Annual Revenue
73%
Organic Traffic

"In a crowded heart failure landscape, AnaCardio's approach isn't just different—it's fundamentally disruptive."

The Novel Mechanism

AnaCardio isn't tweaking existing treatments—they're targeting an entirely new mechanism to improve cardiac contractility. This isn't incremental innovation; it's a potential paradigm shift in heart failure therapeutics. With Allan Gordon as CMO and Elin Rosendahl as CDO, they've assembled the clinical and development expertise to navigate this high-risk, high-reward path.

The Market Reality

Heart failure affects 26M people globally, yet treatment options remain limited. The market is hungry for innovation, and AnaCardio's $44.2M war chest gives them runway to reach clinical inflection points. But here's the catch: with only 329 monthly website visits and 73% organic traffic, their digital footprint is minimal—classic stealth biotech behavior. They're not building a brand; they're building a drug.

The tech stack reveals a pragmatic, cost-conscious approach: WordPress for content, Tailwind and Bootstrap for styling, jQuery for functionality. No fancy AI, no blockchain—just focused execution. The team of 28 includes clinical specialists and business controllers, suggesting a balanced approach between R&D and operational discipline.

  • Targeting a novel cardiac contractility mechanism (not beta-agonists or ARNIs)
  • Lean 28-person team with deep clinical expertise
  • Swedish biotech ecosystem (Gothenburg connection via 'emma alan göteborg' keyword)
  • Revenue-generating despite early stage ($5.6M)
  • 73% organic traffic suggests minimal marketing spend
No public clinical trial data
Strong funding for preclinical/clinical work
Minimal digital presence (329 monthly visits)
Novel mechanism with potential blockbuster applications
No social media profiles listed
Experienced leadership team
Limited backlink data
Revenue generation while in development

The Verdict: High Risk, High Reward

AnaCardio represents the classic biotech bet—minimal noise, maximum scientific ambition. For investors, it's a calculated gamble on novel science. For competitors, it's a reminder that the next breakthrough in heart failure might come from an unexpected mechanism.

What tech stack does Anacardio use?

12 detected
Programming Languages1
Web Standards2
JavaScript Libraries2
Tracking & Analytics1
G
Google Analytics

How much traffic does Anacardio get?

Traffic & Engagement

329
Monthly Visits
1.1
Pages/Visit
0:00
Avg. Duration
38%
Bounce Rate
Monthly Traffic Trend-56%
745
Oct 2025
Oct
287
Nov 2025
Nov
329
Dec 2025
Dec

Traffic Sources

Search
73%
Direct
10%
Social
11%
Referrals
5%
Email
0%
Paid
1%

Where is Anacardio's audience located?

🌍100.0%

What keywords does Anacardio rank for?

2 keywords
1anacardio470 vol$0.26
2emma alan göteborg170 vol

How is Anacardio's SEO?

Open Graph Image

OG Image preview
og:image

https://anacardio.com/wp-content/uploads/2021/04/Favicon.png

Meta Tags

title9 chars

AnaCardio

description144 chars

AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.

languageSV-SE

H1 Tags

h1We are developing novel drugs to treat heart failure

Schema Types

Unknown

What is Anacardio's revenue?

$6M
Annual Revenue
28
47%
Employees
$201K
Revenue/Employee
$44M
Total Funding
Solna, SE
Headquarters

Who works at Anacardio?

Loading leads...

What do customers think of Anacardio?

No Trustpilot reviews available for this company.

Frequently Asked Questions about Anacardio

What is Anacardio's Revenue?
Anacardio generates approximately $6M in annual revenue. With 28 employees, that's $201,000 per employee. The company has raised $44M in total funding.
What does Anacardio do?
AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
How fast is Anacardio growing?
Anacardio employee count has changed by 47% year over year.
What technologies does Anacardio use?
Anacardio uses 11 technologies across their website including Fonts, Programming Languages, CMS. Key technologies include Font Awesome, PHP, WordPress.
Who are Anacardio's competitors?
Anacardio's main competitors include Apotekstjänst, AnaCardio. These companies operate in similar markets and compete for the same customer base.

Export Data

Unlock all exports

Download CSVs, JSONs & full reports

How to contact Anacardio?

What are Anacardio's key pages?

Export anacardio.com Data

Download the complete tech stack, analytics, leads, and company data for anacardio.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.

Raw JSON Data

Click "Show" to view the raw API response data

About anacardio.com

AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.

Company Overview

anacardio.com
Website
329
Monthly Visitors
11
Technologies
6+
Employees

anacardio.com Key Pages

Contact anacardio.com

Technology Stack

anacardio.com uses 11 technologies across their website including Font Awesome, PHP, WordPress, and more.

Fonts

Font Awesome

Programming Languages

PHP

CMS

WordPress

Performance

Lazy Loading, Priority Hints

Web Standards

Twitter Cards, RSS

CSS Frameworks

Bootstrap, Tailwind CSS

Traffic & Audience

329
Monthly Visits
38%
Bounce Rate
1.1
Pages/Visit
0:00
Avg. Duration

anacardio.com receives approximately 329 monthly visitors. The website has a bounce rate of 38% with visitors viewing an average of 1.1 pages per visit. Users spend an average of 0:00 on the site.

The majority of anacardio.com's traffic comes from .

Frequently Asked Questions

What is anacardio.com?
AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
What technologies does anacardio.com use?
anacardio.com uses 11 technologies including Font Awesome, PHP, and 5 more. View the full tech stack analysis above.
How do I contact anacardio.com?
You can contact anacardio.com via email at [email protected] or through their contact page.
How popular is anacardio.com?
anacardio.com receives approximately 329 monthly visitors. Traffic is growing by 14.6% month-over-month.

Related Searches

anacardio.com pricinganacardio.com reviewsanacardio.com alternativesanacardio.com loginanacardio.com careerswhat is anacardio.comanacardio.com tech stackanacardio.com contactanacardio.com vs competitorsanacardio.com featureshow to use anacardio.comanacardio.com integrations

This page provides publicly available information about anacardio.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit anacardio.com directly at https://anacardio.com.